Nuumara Pharma (India) Private Limited
About Nuumara Pharma (India) Private Limited
Data last updated:
Nuumara Pharma (India) Private Limited was a private limited company based in Chandigarh, India, operated as a subsidiary of Preegur Holdings Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 11 March 2015.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2015PTC035449.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Jas Karan Dhaliwal and Pavneet Kaur.
Its last annual general meeting (AGM) was held on 14 August 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at SCO: – 117 – 118 Sector – 17 – B, Chandigarh, India – 160017.
Company details
Contact details
Nuumara Pharma (India) Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO: – 117 – 118 Sector – 17 – B, Chandigarh, India – 160017
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Nuumara Pharma (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nuumara Pharma (India) Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Nuumara Pharma (India) Private Limited, buy the company report.
Board of directors of Nuumara Pharma (India) Private Limited
Nuumara Pharma (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pavneet Kaur | Additional Director | 31 May 2018 | 8 Years 4 Months | As last reported |
| Jas Karan Dhaliwal | Director | 11 Mar 2015 | 11 Years 7 Months | As last reported |
Auditor
Nuumara Pharma (India) Private Limited is audited by ANSHUL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANSHUL & ASSOCIATES | FY 2017 | 028121N |
Shareholding
The shareholding of Nuumara Pharma (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nuumara Pharma (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nuumara Pharma (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuumara Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nuumara Pharma (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nuumara Pharma (India) Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Barry Dean Walter Stecyk ceased to be Director on 31 May 2018.
Frequently asked questions
Nuumara Pharma (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Nuumara Pharma (India) was a private limited company based in Chandigarh, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 11 March 2015 and is registered under CIN U24232CH2015PTC035449. The company has been struck off by the Registrar of Companies and is no longer operational.
Nuumara Pharma (India) had 2 directors:
- Pavneet Kaur - Additional Director
- Jas Karan Dhaliwal - Director
The CIN (Corporate Identification Number) of Nuumara Pharma (India) is U24232CH2015PTC035449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Nuumara Pharma (India) is at SCO: – 117 – 118 Sector – 17 – B, Chandigarh, India – 160017.
Nuumara Pharma (India) was incorporated on 11 March 2015. It is registered with the Registrar of Companies, Chandigarh.
The latest financial statements of Nuumara Pharma (India) on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 14 August 2016. Year-wise statements from 2015 are in the company report.
Nuumara Pharma (India) operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Barry Dean Walter Stecyk ceased to be Director on 31 May 2018. Gagandeep Singh Dhaliwal ceased to be Director on 31 May 2018. John Danylowich ceased to be Director on 31 May 2018. Nuumara Pharma (India) has 5 board changes on record in total.
Nuumara Pharma (India) can be reached at its registered office: SCO: – 117 – 118 Sector – 17 – B, Chandigarh, India – 160017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
